» Articles » PMID: 38997424

Structural Basis of Tethered Agonism and G Protein Coupling of Protease-activated Receptors

Overview
Journal Cell Res
Specialty Cell Biology
Date 2024 Jul 12
PMID 38997424
Authors
Affiliations
Soon will be listed here.
Abstract

Protease-activated receptors (PARs) are a unique group within the G protein-coupled receptor superfamily, orchestrating cellular responses to extracellular proteases via enzymatic cleavage, which triggers intracellular signaling pathways. Protease-activated receptor 1 (PAR1) is a key member of this family and is recognized as a critical pharmacological target for managing thrombotic disorders. In this study, we present cryo-electron microscopy structures of PAR1 in its activated state, induced by its natural tethered agonist (TA), in complex with two distinct downstream proteins, the G and G heterotrimers, respectively. The TA peptide is positioned within a surface pocket, prompting PAR1 activation through notable conformational shifts. Contrary to the typical receptor activation that involves the outward movement of transmembrane helix 6 (TM6), PAR1 activation is characterized by the simultaneous downward shift of TM6 and TM7, coupled with the rotation of a group of aromatic residues. This results in the displacement of an intracellular anion, creating space for downstream G protein binding. Our findings delineate the TA recognition pattern and highlight a distinct role of the second extracellular loop in forming β-sheets with TA within the PAR family, a feature not observed in other TA-activated receptors. Moreover, the nuanced differences in the interactions between intracellular loops 2/3 and the Gα subunit of different G proteins are crucial for determining the specificity of G protein coupling. These insights contribute to our understanding of the ligand binding and activation mechanisms of PARs, illuminating the basis for PAR1's versatility in G protein coupling.

References
1.
Aisiku O, Peters C, De Ceunynck K, Ghosh C, Dilks J, Fustolo-Gunnink S . Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar. Blood. 2015; 125(12):1976-85. PMC: 4366627. DOI: 10.1182/blood-2014-09-599910. View

2.
Qin J, Cai Y, Xu Z, Ming Q, Ji S, Wu C . Molecular mechanism of agonism and inverse agonism in ghrelin receptor. Nat Commun. 2022; 13(1):300. PMC: 8758724. DOI: 10.1038/s41467-022-27975-9. View

3.
Tekin C, Shi K, Daalhuisen J, Ten Brink M, Bijlsma M, Spek C . PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer. Oncotarget. 2018; 9(62):32010-32023. PMC: 6112838. DOI: 10.18632/oncotarget.25880. View

4.
Seeley S, Covic L, Jacques S, Sudmeier J, Baleja J, Kuliopulos A . Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding. Chem Biol. 2003; 10(11):1033-41. DOI: 10.1016/j.chembiol.2003.10.014. View

5.
Qiao A, Han S, Li X, Li Z, Zhao P, Dai A . Structural basis of G and G recognition by the human glucagon receptor. Science. 2020; 367(6484):1346-1352. DOI: 10.1126/science.aaz5346. View